These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17414651)

  • 21. Nighttime blood pressure patterns reveal important information.
    Johns Hopkins Med Lett Health After 50; 2008 May; 20(3):1-2. PubMed ID: 18652031
    [No Abstract]   [Full Text] [Related]  

  • 22. Antihypertensive treatment in the very elderly shows significant mortality benefit.
    Cardiovasc J Afr; 2008; 19(3):169-71. PubMed ID: 18568185
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 24. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) Cohort Study.
    Ishikawa S; Shibano Y; Asai Y; Kario K; Kayaba K; Kajii E
    Hypertens Res; 2007 Jul; 30(7):643-9. PubMed ID: 17785933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes.
    Cardiovasc J Afr; 2007; 18(5):343-4. PubMed ID: 17985038
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hypertension in patients with enhanced cardiovascular risk. Introduction.
    White WB
    Am J Med; 2008 Aug; 121(8 Suppl):S1. PubMed ID: 18638613
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR; Kite A
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrated control of hypertension, dyslipidemia and carotid atherosclerosis in the reduction of cardiovascular risk.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):371-4. PubMed ID: 17489661
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertension in the elderly and the very old.
    Casiglia E; Tikhonoff V; Pessina AC
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):659-65. PubMed ID: 19505281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension and hyperlipidemia].
    Hansen HS; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical practice guideline for cardiovascular risk management in the Netherlands.
    Smulders YM; Burgers JS; Scheltens T; van Hout BA; Wiersma T; Simoons ML;
    Neth J Med; 2008 Apr; 66(4):169-74. PubMed ID: 18424866
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective effects of renin-angiotensin blockade beyond blood pressure control.
    Mancia G; Giannattasio C; Seravalle G; Quarti-Trevano F; Grassi G
    J Hum Hypertens; 2009 Sep; 23(9):570-7. PubMed ID: 19190657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
    Kjeldsen SE; Oparil S; Hedner T; Narkiewicz K
    Blood Press; 2007; 16(1):4-5. PubMed ID: 17453745
    [No Abstract]   [Full Text] [Related]  

  • 40. Gender and the response to blood pressure-lowering treatment.
    Lip GY; Butt M
    Eur Heart J; 2008 Nov; 29(21):2585-6. PubMed ID: 18852182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.